159 related articles for article (PubMed ID: 28925482)
1. MicroRNA-509-5p functions as an anti-oncogene in breast cancer via targeting SOD2.
Song YH; Wang J; Nie G; Chen YJ; Li X; Jiang X; Cao WH
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3617-3625. PubMed ID: 28925482
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2.
Wang HF; Zhang YY; Zhuang HW; Xu M
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3360-3369. PubMed ID: 28829507
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-582-5p suppressed gastric cancer cell proliferation via targeting AKT3.
Jin Y; Tao LP; Yao SC; Huang QK; Chen ZF; Sun YJ; Jin SQ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5112-5120. PubMed ID: 29228422
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-645 suppresses breast cancer cell metastasis via targeting DCDC2.
Cai Y; Li WF; Sun Y; Liu K
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4129-4136. PubMed ID: 29028086
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-645 promotes cell metastasis and proliferation of renal clear cell carcinoma by targeting GK5.
Chen J; Shu Y; Yu Q; Shen W
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4557-4565. PubMed ID: 29131260
[TBL] [Abstract][Full Text] [Related]
6. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
Xia LH; Yan QH; Sun QD; Gao YP
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
[TBL] [Abstract][Full Text] [Related]
8. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
Wang J; Wang S; Zhou J; Qian Q
Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
10. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
11. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
Li H; Bian C; Liao L; Li J; Zhao RC
Breast Cancer Res Treat; 2011 Apr; 126(3):565-75. PubMed ID: 20505989
[TBL] [Abstract][Full Text] [Related]
12. miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.
Zhuang C; Yuan Y; Song T; Wang H; Huang L; Luo X; He H; Huo L; Zhou H; Wang N; Zhang T
Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1112-1121. PubMed ID: 29077787
[TBL] [Abstract][Full Text] [Related]
13. Biological function of microRNA-30c/SOX9 in pediatric osteosarcoma cell growth and metastasis.
Zhang XD; Wang YN; Feng XY; Yang JY; Ge YY; Kong WQ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):70-78. PubMed ID: 29364496
[TBL] [Abstract][Full Text] [Related]
14. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
Zhou L; Zhao LC; Jiang N; Wang XL; Zhou XN; Luo XL; Ren J
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):87-94. PubMed ID: 28121351
[TBL] [Abstract][Full Text] [Related]
16. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
[TBL] [Abstract][Full Text] [Related]
17. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
Tao L; Wu YQ; Zhang SP
Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
[TBL] [Abstract][Full Text] [Related]
18. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
19. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
20. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
